Abstract:Abstract Rationale Studies have confirmed that the lung microbiome of lung transplant recipients is altered and serves as a prognostic indicator for long-term mortality. Other studies reported that the lung microbiome affects host immunity and the transcriptome. However, the lung microbiome composition at the early post-transplant period following lung transplantation is unclear, and the relationship of the lung microbiome with pulmonary immunity and the host transcriptome is also not well understood. Objectives We hypothesize that changes in the lung microbiome composition in the early post-transplant period may have a predictive value for perioperative outcomes following lung transplantation and that the lung microbiome is correlated with pulmonary immunity and the host transcriptome. Thus, this prospective study aimed at observing the lung microbiome composition in the early post-transplant period and the impact of the lung microbiome on pulmonary cytokines and the host transcriptome. Our findings will help us gain a comprehensive understanding of the distribution and significance of the lung microbiome in the early post-transplant period. Methods An observational study was conducted to identify the lung microbiome and the host transcriptome characteristics using next-generation sequencing. Luminex was employed for quantifying alveolar cytokines. Spearman's correlation analysis was utilized to assess the impact of the lung microbiome on pulmonary immunity and differentially expressed genes in patients who died perioperatively after lung transplantation. Results Patients with poor perioperative outcomes showed an increase in Mycoplasma and Arcobacter, a decrease of Gemella, and increased interleukin (IL)-10, IL-1β, and tumor necrosis factor (TNF)-α concentration. The lung microbiome correlates with lung immunity in lung transplant recipients. In the death group, the function of differentially expressed genes is associated with cell apoptosis, and promoting TNF production is upregulated. The lung microbiome is related to differentially expressed genes between the two groups. Conclusions The lung microbiome and cytokines can be considered as potential biomarkers for early prognosis in lung transplant recipients. The lung microbiome is associated with both lung immunity and differentially expressed genes in lung transplant recipients.

MicroRNAs Implicated in Dysregulation of Gene Expression Following Human Lung Transplantation

Microrna Networks In Mouse Lung Organogenesis

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Mir-199B-5p Regulates Immune-Mediated Allograft Rejection after Lung Transplantation Through the GSK3β and NF-κB Pathways

Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation

Microbiosis in Lung Allotransplantation and Xenotransplantation: State of the Art and Future Perspective

Gene Expression Networks in COPD: Microrna and Mrna Regulation

Screening gene signatures for clinical response subtypes of lung transplantation

Pulmonary microRNA profiling: implications in upper lobe predominant lung disease

MicroRNA Profiles in Hematopoietic Stem Cell Transplant Recipients

Understanding the Impact of Macrophages on Lung Transplant Outcomes

Human Lungs Airway Epithelium Upregulate MicroRNA-17 and MicroRNA-548b in Response to Cold Ischemia and Ex Vivo Reperfusion

Association between the lung microbiome and perioperative prognosis in lung transplant recipients

MiRNA-122 Promotes Ischemia-Reperfusion Injury after Lung Transplantation via the Toll-like Receptor Signaling Pathway

Transcriptome analysis of novel macrophage M1-related biomarkers and potential therapeutic agents in ischemia-reperfusion injury after lung transplantation based on the WGCNA and CIBERSORT algorithms

Regulation of cardiac allograft immune responses by microRNA-155

Role of MicroRNA-155 in Allograft Rejection

Ischemia Reperfusion Responses in Human Lung Transplants at the Single Cell Resolution

Defining a natural killer cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies

LncRNA H19 aggravates primary graft dysfunction after lung transplantation via KLF5-mediated activation of CCL28

Microbiome and metabolome patterns after lung transplantation reflect underlying disease and chronic lung allograft dysfunction